TB-500, a synthetic analogue of thymosin beta-4, is a 43-amino acid peptide that was first characterized in the 1960s from bovine thymus tissue and has since been studied for its regenerative effects in wound healing and tissue remodeling
These peptides are known for their ability to boost blood flow, repair tissue, reduce scalp inflammation, and help reactivate dormant follicles
The lessons here apply to anyone navigating the complicated world of grey-market peptides , and the risks extend far beyond one shuttered website
Long-term risks unknown: Chronic use could have consequences that have not yet been documented
These findings suggest a synergistic network of neuroprotective signalling, with GLP-1 and GLP-2 able to enhance or trigger VIPs protective actions
4 TREATMENT PROTOCOL Your new treatment program will inform therapy